Hematopoietic and Lymphoid Cell Neoplasm
195
28
92
63
Key Insights
Highlights
Success Rate
76% trial completion
Published Results
54 trials with published results (28%)
Research Maturity
63 completed trials (32% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 47/100
10.3%
20 terminated out of 195 trials
75.9%
-10.7% vs benchmark
8%
16 trials in Phase 3/4
86%
54 of 63 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 63 completed trials
Clinical Trials (195)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Testing the Effects of Exercise on Chemotherapy-Induced Peripheral Neuropathy
Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis
CMV-MVA Triplex Vaccination of Stem Cell Donors in Preventing CMV Viremia in Participants With Allogeneic Transplant
Whole Body Vibration for the Improvement of Health and Functioning in Participants With Chemotherapy-Induced Peripheral Neuropathy
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host Disease
Testing Crizotinib as a Potential Targeted Treatment in Cancers With ROS1 Genetic Changes (MATCH-Subprotocol G)
Hu8F4 in Treating Patients With Advanced Hematologic Malignancies
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
Mobile App to Help Survivors of Childhood Cancer Navigate Long-Term Follow-Up Care
Testing AZD9291 as Potentially Targeted Treatment in Cancers With EGFR Genetic Changes (MATCH-Subprotocol E)
Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia
Non-invasive Ventilation in Reducing the Need for Intubation in Patients With Cancer and Respiratory Failure
Patient Reported Symptom Control With THC or CBD Use
Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia
Testing Afatinib as a Potential Targeted Treatment in Cancers With HER2 Genetic Changes (MATCH-Subprotocol B)
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program